Fish oil and treatment of cancer cachexia

Genes and Nutrition

Volumn 3, Issue 1, 2008, Pages 25-28

  Giacosa, Attilio ^a,c   Rondanelli, Mariangela ^b  

^a Policlinico di Monza   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Policlinico di Monza   (Italy)

Author keywords

Cancer cachexia; Fatty acids; Fish oil; Omega 3

Indexed keywords

ALPHA TOCOPHEROL; AMINO ACID DERIVATIVE; ANABOLIC AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; APPETITE STIMULANT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CANNABINOID; CHEMOKINE RECEPTOR ANTAGONIST; CORTICOSTEROID; CREATINE; CYTOKINE; FISH OIL; GHRELIN; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INSULIN; MACROLIDE; MEDIUM CHAIN FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PENTOXIFYLLINE; POLYUNSATURATED FATTY ACID; SOMATOMEDIN; THALIDOMIDE; UNINDEXED DRUG; UNSATURATED FATTY ACID;

ADVANCED CANCER; BREAST CANCER; CACHEXIA; CANCER RISK; CANCER STAGING; COLON CANCER; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; EARLY INTERVENTION; EXERCISE; FOOD INTAKE; HUMAN; LEAN BODY WEIGHT; LONG TERM CARE; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; METABOLIC DISORDER; NEUROENDOCRINE SYSTEM; NUTRITIONAL SUPPORT; PANCREAS CANCER; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 49749149536     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-008-0078-1     Document Type: Review

References (11)

1. Baracos VE (2006) Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 26:435-461
2. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80-86
3. Bossola M, Muscaritoli M, Costelli P, Grieco G, Bonelli G, Pacelli F, Rossi Fanelli F, Doglietto GB, Baccino FM (2003) Increased muscle proteasome activity correlates with disease severity in gastric cancer patients. Ann Surg 237:384-389
4. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, Garcia Peris P, Garcia-de-Lorenzo A, Zarazaga A, Quecedo L, Del Llano J, Usan L, Casimiro C (2007) n-3 Fatty acids, cancer and cachexia: A systemic review of the letterature. Brit J Nutr 97:823-831
5. Fearon KCH, von Meyenfeldt MF, Moses AGW, van Geenen R, Roy A, Gouma DJ, Giacosa A,Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ (2003) Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. GUT 52:1479-1486
6. Giacosa A, Frascio F, Sukkar SG, Roncella S (1996) Food intake and body composition in cancer cachexia. Nutrition 12:S20-S23
7. Grimm H, Mertes N, Goeters C, Schlotzer E, Mayer K, Grimminger F, Furst P (2006) Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45:55-60
8. Jatoi A (2005) Omega-3 fatty acid supplements for cancer-associated weight loss. Nutr Clin Pract 4:394-349
9. Moses A, Slater C, Preston T, Barber M, Fearon K (2004) Reduced total energy expenditure and physical activityin cachectic patients with pancreatic cancer can be modulated by energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Can 90:996-1002
10. Stehr SN, Heller AR (2006) Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clin Chim Acta 373:1-8
11. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC, Fearon KCH (1996) The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12:S27-S30